Mori Arkin

About

Portfolio · 4

OdysightAI

Visual Sensing and Video-Based Predictive Maintenance Systems

1 round $14.0M committed Latest: 2023-03

TopGum Industries

Functional, Sugar-free, Gummy Supplements

1 round $20.0M committed Latest: 2020-11

Butterfly Medical

Implantable Device for Nonsurgical BPH Treatment

2 rounds $9.0M committed Latest: 2020-10

Phytolon

Production of Natural Food Colorants

1 round $4.0M committed Latest: 2020-09

Investment activity

1 portfolio exit on record.

Q&A

What is Mori Arkin's primary investment focus based on recent portfolio activity?

Mori Arkin's recent portfolio activity shows a focus on Agriculture & Food Technologies and Health Tech & Life Sciences, with two companies in each sector. Additionally, there is one company in Industrial Technologies.

Which notable companies are in Mori Arkin's current portfolio?

Mori Arkin's portfolio includes Butterfly Medical, which develops an implantable device for nonsurgical BPH treatment, and OdysightAI, focused on visual sensing and video-based predictive maintenance systems.

Has Mori Arkin had any notable exits recently?

Yes, Mori Arkin had an exit in August 2021 with TopGum Industries, a company producing functional, sugar-free gummy supplements, which went public on the TASE with a valuation of $165.79M.

What is Mori Arkin's investment stage preference?

Mori Arkin has participated in various stages, including an A Round, a B Round, Convertible Debt, and PIPE rounds.

Can you provide an example of a recent investment by Mori Arkin?

In March 2023, Mori Arkin invested in Phytolon, a company focused on the production of natural food colorants, which raised $20.25M in its Series A round.

What is Mori Arkin's role within Arkin Capital?

Mori Arkin is the chairman of Arkin Capital. The investments listed reflect past activities of Arkin Holding before its reorganization into different entities like Arkin Digital Health, Arkin Bio, Arkin Tech, and Arkin Equity.